Abstract
Five patients with primary biliary cirrhosis and vitamin D deficiency (serum 25-hydroxyvitamin D less than 6 ng/ml) are presented. All patients had low serum 24, 25-dihydroxyvitamin D3 concentrations. Three patients had histological osteomalacia, negative calcium balance, and subnormal serum 1,25-dihydroxyvitamin D3. Malabsorption of a standard dose of [3H]vitamin D3 was found in three of four patients with steatorrhea, enabling the effective dose of vitamin D3 given to be calculated. Oral vitamin D3 400–4000 IU/day (effectively 400–1860 IU/day) resulted in a return to normal of the serum vitamin D metabolites, correction of the impaired intestinal calcium absorption and healing of the osteomalacia. Increases in serum calcium, phosphate, and the renal tubular reabsorption of phosphate occurred with a concomitant decrease in serum parathyroid hormone. It is suggested that osteomalacia in primary biliary cirrhosis is the end result of vitamin D deficiency; the hepatic and renal hydroxylations of vitamin D are normal and target tissues are responsive to endogenously produced metabolites of vitamin D.
Similar content being viewed by others
References
Atkinson M, Nordin BEC, Sherlock S: Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med 25:299–312, 1956
Kehayoglou AK, Holdsworth CD, Agnew JE, Whelton MJ, Sherlock S: Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1:715–719, 1968
Ajdukiewicz AB, Agnew JE, Byers PD, Wills MR, Sherlock S: Relief of bone pain in primary biliary cirrhosis with calcium infusions. Gut 15:788–793, 1974
Long RG, Meinhard E, Skinner RK, Varghese Z, Wills MR, Sherlock S: Clinical biochemical and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease. Gut 19:85–90, 1978
Compston JE, Horton LWL, Thompson RPH: Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25 hydroxyvitamin D3. Gut 20:133–136, 1979
Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL: Bone disease in primary biliary cirrhosis: Reversal of osteomalacia with oral 25 hydroxyvitamin D. Gastroenterology 78:512–517, 1980.
Long RG, Varghese Z, Meinhard EA, Skinner RK, Wills MR, Sherlock S: Parenteral 1,25 dihydroxycholecalciferol in hepatic osteomalacia. Br Med J 1:75–77, 1978
Compston JE, Crowe JP, Horton LWL: Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1 alpha hydroxyvitamin D3. Br Med J 2:309, 1978
Ponchon G, Deluca HF: The role of the liver in the metabolism of vitamin D. J Clin Invest 48:1273–1279, 1969
Wagonfeld JB, Nemchausky BA, Bolt M, Vander Horst J, Boyer JL, Rosenberg IH: Comparison of vitamin D and 25 hydroxyvitamin in the therapy of primary biliary cirrhosis. Lancet 2:391–394, 1976
Skinner RK, Long RG, Sherlock S, Wills MR: 25 Hydroxylation of vitamin D in primary biliary cirrhosis. Lancet 1:720–721, 1977
Krawitt EL, Grundman ML, Mawer EB: Absorption hydroxylation and excretion of vitamin D3 in primary biliary cirrhosis. Lancet 2:1246–1249, 1977
Ludwig J, Dickson ER, McDonald GSA: Staging of chronic non-supparative destructive cholangitis (syndrome of primary biliary cirrhosis).Virchow's Arch A 379:103–112, 1978
Thompson WG, Thompson GR: Effect of cholestyramine on the absorption of vitamin D3 and calcium. Gut 10:717–722, 1969
Davies M, Mawer EB, Adams PH: Vitamin D metabolism and response to 1,25 dihydroxycholecalciferol in osteoporosis. J Clin Endocrinol Metab 45:199–208, 1977
Taylor CM, Mawer EB, Wallace JE, Cochran M, Russell RGG, Kanis JA: The absence of 24,25-dihydroxycholecalciferol in anephric patients. Clin Sci Mol Med 55:541–547, 1978
Clemens TL, Hendy GN, Papapoulos SE, Fraher LJ, Care AD, O'Riordan JLH: Measurement of 1,25 dihydroxycholecalciferol in man by radioimmunoassay. Clin Endocrinol 11:225–234, 1979
Mawer EB, Backhouse J, Hill LF, Lumb GA, de Silva P, Taylor CM, Stanbury SW: Vitamin D metabolism and parathyroid function in man. Clin Sci Mol Med 48:349–365, 1975
Walton RJ, Bijvoet OLM: Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310, 1975
Davies M, Mawer EB, Krawitt EL: Comparative absorption of vitamin D3 and 25 hydroxyvitamin D3 in intestinal disease. Gut 21:287–292, 1980
Recommended daily amount of food, energy and nutrients for groups of people in the United Kingdom, DHSS. Report on Health and Social Subjects 15. London, HMSO, 1979
Stanbury SW, Taylor CM, Lumb GA, Mawer EB, Berry J, Hann J, Wallace J: Formation of vitamin D metabolites following correction of human vitamin D deficiency. Miner Electrolyte Metab 5:212–227, 1981
Davies M, Mawer EB: The absorption and metabolism of vitamin D3 from parenteral injection sites.In Vitamin D, Basic Research and Its Clinical Application. Proceedings of the Fourth Workshop on Vitamin D. AW Norman, K Shaffer, DV Herrath (eds). Berlin, Walter de Gruyter, 1979, pp 609–612
Long RG, Skinner RK, Wills MR, Sherlock S: Formation of vitamin D metabolites from3H and14C radiolabelled vitamin D3 in chronic liver disease. Clin Chim Acta 85:311–317, 1978
Mawer EB: The role of the liver in the control of vitamin D metabolism.In Vitamin D, Basic Research and Its Clinical Application. Proceedings of the Fourth Workshop on Vitamin D. AW Norman, K Schaffer, DV Herrath (eds). Berlin, Walter de Gruyter, 1979, pp 553–561
Papapoulos SE, Clemens TL, Fraher LJ, Gleed J, O'Riordan JLH: Metabolites of vitamin D in human vitamin D deficiency. Effect of vitamin D3 or 1,25 dihydroxycholecalciferol. Lancet 2:612–615, 1980
Kaplan MM, Goldberg MJ, Matloff DS, Neer RM, Goodman DBP: Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis. Gastroenterology 81:681–685, 1981
Compston JE, Crowe JP, Wells IP, Horton LWL, Hirst D, Merrett AL, Woodhead JS, Williams R: Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease. Dig Dis Sci 25:28–32, 1980
Stanbury SW, Mawer EB, Lumb GA, Hill LF, Holman CA, Jones M, van den Berg CJ: Some aspects of vitamin D metabolism in man.In Endocrinology 1971. S Taylor (ed). London, William Heineman, 1971, pp 487–499
Clemens TL, Adams JS, Henderson SL, Holick MF: Increased skin pigment reduces the capacity of skin to synthesize vitamin D3. Lancet 1:74–76, 1982
Nagubandi S, Kumar R, Londowski JM, Corradino RA, Tietz PS: Role of vitamin D glucosiduronate in calcium homeostasis. J Clin Invest 66:1274–1280, 1980
Arnaud SB, Goldsmith RS, Lambert PW, Go VLW: 25 Hydroxyvitamin D3: Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 149:570–572, 1975
Author information
Authors and Affiliations
Additional information
Supported by a grant from the British Medical Research Council to Professor S. W. Stanbury.
Rights and permissions
About this article
Cite this article
Davies, M., Mawer, E.B., Klass, H.J. et al. Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Digest Dis Sci 28, 145–153 (1983). https://doi.org/10.1007/BF01315144
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01315144